{
    "startDate": "2021-01-01",
    "endDate": "2021-12-31",
    "year": "2021",
    "quarter": "FY",
    "symbol": "ACHV",
    "data": {
        "bs": [
            {
                "label": "Other assets and restricted cash [note 7, note 8 and note 9]",
                "concept": "achv:OtherAssetsAndRestrictedCash",
                "unit": "usd",
                "value": 183000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 121545000
            },
            {
                "label": "Long-term obligations [note 13]",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 4000
            },
            {
                "label": "Accrued clinical liabilities",
                "concept": "achv:AccruedLiabilitiesClinicalCurrent",
                "unit": "usd",
                "value": 1352000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 47516000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 47516000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 841000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 28042000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 28042000
            },
            {
                "label": "Grant receivable [note 4]",
                "concept": "GrantsReceivableCurrent",
                "unit": "usd",
                "value": 153000
            },
            {
                "label": "Right-of-use assets [note 13]",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 64000
            },
            {
                "label": "Current portion of long-term obligations [note 13]",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 69000
            },
            {
                "label": "Goodwill [note 5]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 1034000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 19474000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1940000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1419000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -93586000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -93600000.0
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 44594000
            },
            {
                "label": "Common stock, $0.001 par value, 150,000,000 shares authorized, 9,453,542 and 6,111,735 issued and outstanding at December 31, 2021 and December 31, 2020, respectively.",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 79000
            },
            {
                "label": "Accrued liabilities other",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 348000
            },
            {
                "label": "Commitments and contingencies [note 13]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "License agreement [note 5 and 6]",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 1641000
            },
            {
                "label": "License agreement [note 5 and 6]",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 1641000
            },
            {
                "label": "Convertible debt [note 10]",
                "concept": "ConvertibleDebtNoncurrent",
                "unit": "usd",
                "value": 14920000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 4550000
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 4000
            },
            {
                "label": "Cash and cash equivalents [note 7]",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 43022000
            },
            {
                "label": "Cash and cash equivalents [note 7]",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 43000000.0
            }
        ],
        "cf": [
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 228000
            },
            {
                "label": "Proceeds from exercise of warrants",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 338000
            },
            {
                "label": "Net increase (decrease) in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 7169000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayableTrade",
                "unit": "usd",
                "value": 509000
            },
            {
                "label": "Amortization [note 5]",
                "concept": "AdjustmentForAmortization",
                "unit": "usd",
                "value": 223000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 27000
            },
            {
                "label": "Stock-based compensation [note 12[c]]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 2187000
            },
            {
                "label": "Stock-based compensation [note 12[c]]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 2187000
            },
            {
                "label": "Accrued liabilities other",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": -245000
            },
            {
                "label": "Effect of exchange rate changes on cash",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -33152000
            },
            {
                "label": "Shares issued as settlement with trade vendor",
                "concept": "achv:SharesIssuedAsSettlementWithTradeVendorAsNonMonetaryTransaction",
                "unit": "usd",
                "value": 41000
            },
            {
                "label": "Accrued clinical liabilities",
                "concept": "achv:IncreaseDecreaseInAccruedClinicalLiabilities",
                "unit": "usd",
                "value": 899000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": 466000
            },
            {
                "label": "Lease obligation",
                "concept": "achv:IncreaseDecreaseInLeaseObligations",
                "unit": "usd",
                "value": 14000
            },
            {
                "label": "Grant receivable [note 4]",
                "concept": "achv:IncreaseDecreaseInGrantsReceivable",
                "unit": "usd",
                "value": 153000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -29440000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -29400000.0
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 36610000
            },
            {
                "label": "Receipt of convertible debt from SVB [note 10]",
                "concept": "ProceedsFromConvertibleDebt",
                "unit": "usd",
                "value": 14929000
            }
        ],
        "ic": [
            {
                "label": "Other expenses",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -75000
            },
            {
                "label": "Basic and diluted net loss per common share [note 1 and note 12 [g]]",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -4.08
            },
            {
                "label": "Basic and diluted net loss per common share [note 1 and note 12 [g]]",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -4.08
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 23966000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 17000
            },
            {
                "label": "Total other income (expense)",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -58000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 9128000
            },
            {
                "label": "Shares used in computation of basic and diluted net loss per common share [note 1 and note 12 [g]]",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 8119836
            },
            {
                "label": "Shares used in computation of basic and diluted net loss per common share [note 1 and note 12 [g]]",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 8119836
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -33152000
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -33152000
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -33200000.000000004
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -33152000
            },
            {
                "label": "Total operating expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 33094000
            }
        ]
    }
}